Current Clincial Trials available through the NICRC

Cancer Control/Prevention/Symptom Management
 

Celgene-Connect MDS and AML  The Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease Registry

IU1201007864  Health Utilities and Quality of LIfe Among Women with Gynecologic Malignancies

Colon

NSABP MPR-1- Patient Registry and Biospecimen Profiling Repository

RU0214071-Patients with Refractory Metastatic Colorectal Cancer (mCRC)

RU021407I Regorafenib Dose Optimization Study (reDOS): A Phase II Randomized Study of Lower Dose Regorafenib Compared to Standard Dose REgorafenib in Patients with Refractory Metastatic Colorectal Cancer (mCRC)

Esophageal

BBI608-336 (BRIGHTER) A phase III Randomized, Double-Blind, Placebo-Controlled Clinical Trial of BBI608 plus Weekly Paclitaxel vx. Placebo plus Weekly Paclitaxel in Adult Patients with Advanced, Previously Treated Gastric and Gastro-Esophageal Junction Adenocarcinoma

Lung 

HCRN LUN14-179-Concurrent chemoradiation with consolidation Pembrolizumab (MK3475 or Keytruda) for the treatment of inoperable or unresectable stage III non-small cell lung cancer

Multiple Myeloma
 

ConnectTM MM- Multiple Myeloma Disease Registry

Non Hodgkin's Lymphoma
 

CC-5013-NHL-007  A Phase 3, Double-BLind Randomized Study to Compare the EFficacy and Safety of Rituximab Plus Lenalidomide (CC-5013) Versus Rituximab Plus Placebo in Subjects with Relapsed/REfractory Indolent Lymphoma (Rituximab Naive) 

Prostate

P12-1 PREDICT- Positive Imaging Study For Distant Metastases In Patients With Castration-Resistant Prostate Cancer